Offspring of male and female parents with thalidomide embryopathy:: Birth defects and functional anomalies

被引:19
作者
Strömland, K [1 ]
Philipson, E
Grönlund, MA
机构
[1] Queen Silvia Childrens Hosp, Dept Pediat Ophthalmol, SE-41685 Gothenburg, Sweden
[2] Univ Gothenburg, Inst Clin Neurosci, Ophthalmol Sect, Gothenburg, Sweden
关键词
D O I
10.1002/tera.10083
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The aim of the study was to evaluate congenital malformations and functional anomalies in the offspring of Swedish parents with thalidomide embryopathy (TE). Methods: Sixty-four children (29 girls, 35 boys) with ages ranging from 0-18 years, born to 34 Swedish parents (14 women, 20 men) with TE, were studied. Data on malformations and dysfunction were collected from medical records at maternity and child healthcare units, delivery units, hospitals, outpatient clinics and schools. Results: Five children had both a mother and father with TE, 23 had a mother suffering from TE, and in 36 children the father had TE. One girl had a major malformation consisting of pulmonary stenosis, and single cases of minor physical features and positional deformities were observed. One boy had autism. Four children were born preterm, all to a TE mother. One child died within 24 hr after birth. Seven spontaneous abortions were registered, five of them in TE mothers. The cesarian section rate was 39% among the TE mothers, compared to 14% among the non-TE mothers. Conclusions: Malformations or functional anomalies similar to those typical for TE were not found in this group of children born to Swedish parents with TE. Cesarian sections were more frequently performed in TE mothers, partly because of pelvic and uterine malformations.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 40 条
[1]   Thalidomide: lack of mutagenic activity across phyla and genetic endpoints [J].
Ashby, J ;
Tinwell, H ;
Callander, RD ;
Kimber, I ;
Clay, P ;
Galloway, SM ;
Hill, RB ;
Greenwood, SK ;
Gaulden, ME ;
Ferguson, MJ ;
Vogel, E ;
Nivard, M ;
Parry, JM ;
Williamson, J .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 396 (1-2) :45-64
[2]   IS THALIDOMIDE MUTAGENIC [J].
ASHBY, J ;
TINWELL, H .
NATURE, 1995, 375 (6531) :453-453
[3]   CLINICAL AND BASIC SCIENCE LESSONS FROM THE THALIDOMIDE TRAGEDY - WHAT HAVE WE LEARNED ABOUT THE CAUSES OF LIMB DEFECTS [J].
BRENT, RL ;
HOLMES, LB .
TERATOLOGY, 1988, 38 (03) :241-251
[4]  
Brent RL, 1999, TERATOLOGY, V59, P182, DOI 10.1002/(SICI)1096-9926(199904)59:4<182::AID-TERA2>3.0.CO
[5]  
2-H
[6]  
DARCY PF, 1994, ADVERSE DRUG REACT T, V13, P65
[7]  
HOFFMANN W, 1976, GEBURTSH FRAUENHEILK, V36, P1066
[8]  
Holmes LB, 1999, TERATOLOGY, V59, P1
[9]  
JENSEN MK, 1965, ACTA MED SCAND, V177, P783
[10]   THALIDOMIDE MAY NOT BE A MUTAGEN [J].
KIDA, M .
BRITISH MEDICAL JOURNAL, 1994, 309 (6956) :741-741